Cancer stem cell markers in common cancers – therapeutic implications
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 14 (10), 450-460
- https://doi.org/10.1016/j.molmed.2008.08.003
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applicationsJournal of Molecular Medicine, 2008
- Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse modelBreast Cancer Research and Treatment, 2008
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent®) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006
- Cancer genes and the pathways they controlNature Medicine, 2004
- Hepatocellular carcinomaJournal of Hepatology, 2000